BRAF and cancer: In the present case we report a AKT1 c.49G > A p.(Glu17Lys) exon 4 variant, a hotspot mutation which is commonly associated with various cancers, including breast, colorectal and lung [14], but has also been recently identified in an ameloblastoma with a BRAF mutated background [15].